SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia
Clinical trial NCT00364429 · TERMINATED
Trial details
- NCT number
- NCT00364429
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2005-07-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.